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Identity 
Other names: BSAP (B-cell lineage specific activator 
protein) 




The PAX5 coding region extends over a genomic 
interval of approximately 200 kb and comprises 10 
exons. 
Transcription 
Two alternative transcripts have been identified, 
originating from alternative promotor usage, contaiing 
exon 1A or 1B; full length mRNA is 3650 bp; 
transcription is from centromere to telomere. 
Protein 
Description 
391 amino acids, 42 kDa, PAX5 belongs to the paired 
box family of transcription factors, contains a paired 
box (DNA binding) domain, a truncated homeo domain 













Involved in a multitude of developmental processes, 
PAX5 expression is not only continuously required for 
B cell lineage commitment during early B cell 
development but also for B lineage maintenance, 
involved in the regulation of the CD19 gene, a B-






PAX5 - IGH juxtaposition. 
dic(9;12)(p13;p13) acute lymphoblastic 
leukemia 
Hybrid/Mutated gene 
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